Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA panel backs Amgen's cholesterol drug for high-risk patients
FDA panel backs Amgen's cholesterol drug for high-risk patients
FDA panel backs Amgen's cholesterol drug for high-risk patients
Submitted by
admin
on June 10, 2015 - 6:13pm
Source:
Yahoo/Reuters
News Tags:
FDA
Amgen
Repatha
advisory panels
PCSK9 inhibitors
Headline:
FDA panel backs Amgen's cholesterol drug for high-risk patients
Do Not Allow Advertisers to Use My Personal information
